A.G.P./Alliance Global Partners, a full-service, regional investment firm, has expanded its Research Team with the hiring of Matthew Cross, as a Senior Biotechnology Research Analyst
A.G.P./Alliance Global Partners, a full-service, regional investment firm, has expanded its Research Team with the hiring of Matthew Cross, as a Senior Biotechnology Research Analyst.
A.G.P./Alliance Global Partners, a full-service, regional investment firm, has expanded its Research Team with the hiring of Matthew Cross, as a Senior Biotechnology Research Analyst.
Mr. Cross will be a senior member of the A.G.P. Equity Research Team. He will be focused on small-mid cap oncology and strengthening relationships across a wide range of therapeutic areas and treatment modalities.
He joins us from JonesTrading as a Senior Biotechnology Analyst, and has previously worked at H.C. Wainwright and CanaccordGenuity, providing support for coverage of companies in the biotech and specialty pharma sectors.
Mr. Crossgraduated Trinity University, where he designed and conducted clinical trials in the field of behavioral psychology before ultimately entering equity research.
Phil Michals, Executive Chairman commented: “We continue to expand our research coverage and Matt is an important addition in that effort”. “His knowledge in the sector will make an immediate impact with our clients”.